DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.123.320443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Qi Feng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei Province, China (Q.F., C.Y.…. Hauptthemen laut MEDLINE: Endocytosis, Vascular Endothelial Growth Factor Receptor-2, Neovascularization, Physiologic, Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Unwanted angiogenesis is involved in the progression of various malignant tumors and cardiovascular diseases, and the factors that regulate angiogenesis are potential therapeutic targets. We tested the hypothesis that DCBLD1 (discoidin, CUB, and LCCL domain-containing protein 1) is a coreceptor of VEGFR-2 (vascular endothelial growth factor receptor-2) and modulates angiogenesis in endothelial cells. METHODS: A carotid artery ligation model and retinal angiogenesis assay were used to study angiogenesis using globe knockout or endothelial cell–specific conditional Dcbld1 knockout mice in vivo. Immunoblotting, immunofluorescence staining, plasma membrane subfraction isolation, Coimmunoprecipitation, and mass spectrum assay were performed to clarify the molecular mechanisms. RESULTS: Loss of Dcbld1 impaired VEGF (vascular endothelial growth factor) response and inhibited VEGF-induced endothelial cell proliferation and migration. Dcbld1 deletion interfered with adult and developmental angiogenesis. Mechanistically, DCBLD1 bound to VEGFR-2 and regulated the formation of VEGFR-2 complex with negative regulators: protein tyrosine phosphatases, E3 ubiquitin ligases (neuronal precursor cell-expressed developmentally downregulated gene 4, Nedd4 and c-Casitas B-lineage lymphoma, c-Cbl), and also Dcbld1 knockdown promoted lysosome-mediated VEGFR-2 degradation in endothelial cells. CONCLUSION: These findings demonstrated the essential role of endothelial DCBLD1 in regulating VEGF signaling and provided evidence that DCBLD1 promotes VEGF-induced angiogenesis by limiting the dephosphorylation, ubiquitination, and lysosome degradation after VEGFR-2 endocytosis. We proposed that endothelial DCBLD1 is a potential therapeutic target for ischemic cardiovascular diseases by the modulation of angiogenesis through regulation of the VEGFR-2 endocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei Province, China (Q.F., C.Y., L.G., X.L., Y.L., C.L., W.Z., Y.Z., W.Y., Y.M., R.W., L.L., Y.P., H.…
- The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, Hebei Province, China (Q.F., C.Y., L.G., X.L., Y.L., C.L., W.Z., Y.Z., W.Y., Y.M., R.W., L.L., Y.P., H.W.…
- Key Laboratory of Vascular Biology in Hebei Province, Hebei Medical University, Shijiazhuang, Hebei Province, China (Q.F., C.Y., L.G., X.L., Y.L., C.L., W.Z., Y.Z., W.Y., Y.M., R.W., L.L., Y.P., H.W., M.H., L.N.).
- Cardiovascular Medical Science Center, Hebei Medical University, Shijiazhuang, Hebei Province, China (Q.F., C.Y., L.G., X.L., Y.L., C.L., W.Z., Y.Z., W.Y., Y.M., R.W., L.L., Y.P., H.W., D.L., H.N., M.H., L.N.).
- Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China (D.L.).
- School of Nursing, Hebei Medical University, Shijiazhuang, Hebei Province, China (H.N.).
ORCID-Profile: Qi Feng, Yanling Lin, Yunli Pei, Huifang Wang, Demin Liu, Honglin Niu, Mei Han, Lei Nie
Zitieren
APA
Feng, Q., Yu, C., Guo, L., Liu, X., Lin, Y., Li, C., Zhang, W., Zong, Y., Yang, W., Ma, Y., Wang, R., Li, L., Pei, Y., Wang, H., Liu, D., Niu, H., Han, M., & Nie, L. (2025). DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320443
Vancouver
Feng Q, Yu C, Guo L, Liu X, Lin Y, Li C, et al. DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.123.320443
BibTeX
@article{Feng2025,
author = {Feng, Qi and Yu, Chao and Guo, Lingling and Liu, Xiaoning and Lin, Yanling and Li, Chenyang and Zhang, Wenjun and Zong, Yanhong and Yang, Weiwei and Ma, Yuehua and Wang, Runtao and Li, Lijing and Pei, Yunli and Wang, Huifang and Liu, Demin and Niu, Honglin and Han, Mei and Nie, Lei},
title = {DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.123.320443}
}
EUVIMED